BR0007513A - Fosfatidilinositóis sulfatados, sua preparação euso - Google Patents

Fosfatidilinositóis sulfatados, sua preparação euso

Info

Publication number
BR0007513A
BR0007513A BR0007513-2A BR0007513A BR0007513A BR 0007513 A BR0007513 A BR 0007513A BR 0007513 A BR0007513 A BR 0007513A BR 0007513 A BR0007513 A BR 0007513A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
phosphatidylinositols
sulphated
preparation
sulfated phosphatidylinositol
Prior art date
Application number
BR0007513-2A
Other languages
English (en)
Inventor
Eric J Dadey
Xiao-Hui Mei
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of BR0007513A publication Critical patent/BR0007513A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"FOSFATIDILINOSITóIS SULFATADOS, SUA PREPARAçãO EUSO". Um fosfatidilinositol sulfatado, composições farmacêuticascontendo um fosfatidilinositol sulfatado, e a administração de umfosfatidilinositol sulfatado ou de composições farmacêuticas aindivíduos são mostrados. Um fosfatidilinositol sulfatado pode serusado sozinho para a extração de uma resposta farmacológica, oupode ser incorporado em uma variedade de composiçõesfarmacêuticas, líquidas e sólidas, como um componente de umsistema de envio de droga para a administração de um agenteterapêutico a um indivíduo.
BR0007513-2A 1999-01-15 2000-01-12 Fosfatidilinositóis sulfatados, sua preparação euso BR0007513A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11616699P 1999-01-15 1999-01-15
PCT/US2000/000749 WO2000042050A1 (en) 1999-01-15 2000-01-12 Sulfated phosphatidylinositols, their preparation and use

Publications (1)

Publication Number Publication Date
BR0007513A true BR0007513A (pt) 2001-11-20

Family

ID=22365644

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007513-2A BR0007513A (pt) 1999-01-15 2000-01-12 Fosfatidilinositóis sulfatados, sua preparação euso

Country Status (12)

Country Link
US (1) US6316424B1 (pt)
EP (1) EP1144420B1 (pt)
JP (1) JP2002534528A (pt)
AT (1) ATE256134T1 (pt)
AU (1) AU2503900A (pt)
BR (1) BR0007513A (pt)
CA (1) CA2356306C (pt)
DE (1) DE60007074T2 (pt)
DK (1) DK1144420T3 (pt)
ES (1) ES2214249T3 (pt)
PT (1) PT1144420E (pt)
WO (1) WO2000042050A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020065927A1 (en) 2000-09-05 2002-05-30 Janik Craig M. Webpad and method for using the same
US20050084513A1 (en) * 2003-10-21 2005-04-21 Board Of Regents Nanocoating for improving biocompatibility of medical implants
US20050239747A1 (en) * 2004-04-21 2005-10-27 Pharmaceutical Industry Technology And Development Center Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods
TW200846031A (en) * 2007-05-25 2008-12-01 Shu-Yi Lin Drug delivery system and the preparing method thereof
EP2231694A4 (en) * 2007-12-18 2010-12-29 Agency Science Tech & Res PEPTIDE CATIONIC NANOPARTICLES WITH CORE-ENVELOPE
US8715987B2 (en) * 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
CN108586574B (zh) * 2018-04-26 2019-11-12 国家海洋局第三海洋研究所 氨基葡萄糖肽类化合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293826A3 (en) * 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US6602861B1 (en) * 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
WO1997043296A1 (fr) * 1996-05-16 1997-11-20 Nissin Food Products Co., Ltd. Nouveaux composes a activite antivirale

Also Published As

Publication number Publication date
CA2356306C (en) 2006-02-21
JP2002534528A (ja) 2002-10-15
PT1144420E (pt) 2004-04-30
EP1144420A1 (en) 2001-10-17
ATE256134T1 (de) 2003-12-15
DE60007074T2 (de) 2004-09-16
ES2214249T3 (es) 2004-09-16
WO2000042050A1 (en) 2000-07-20
DK1144420T3 (da) 2004-04-13
DE60007074D1 (de) 2004-01-22
US6316424B1 (en) 2001-11-13
CA2356306A1 (en) 2000-07-20
AU2503900A (en) 2000-08-01
EP1144420B1 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
DK0871748T3 (da) Indgivelse af biologisk aktive polypeptider
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
HUP0101293A2 (hu) AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
DE69940674D1 (de) Orale verabreichung von adenosin analogen
NZ501950A (en) Medicinal compositions for application to mucosa
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE401892T1 (de) Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
AR012376A1 (es) Formulacion de gel para la aplicacion topica
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
ATE292453T1 (de) Antivirale arznei
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
BR0007513A (pt) Fosfatidilinositóis sulfatados, sua preparação euso
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
EA200200914A1 (ru) Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
ATE374600T1 (de) Pharmazeutische formulierung enthaltend olanzapin
DE50005082D1 (de) Verfahren zu Herstellung von PULVERFÖRMIGEn SOLUBILISATIONSHILFSSTOFFEn FÜR FESTE PHARMAZEUTISCHE DARREICHUNGSFORMEN
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
GEP20043377B (en) Pharmaceutical Complex
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
GB0018322D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A, 9A E 10A ANUIDAD(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.